Back to video list Back to Home Eptinezumab – an efficacious, fast and sustained anti-CGRP monoclonal antibody therapy for preventive migraine treatment You may also like Alzheimer's Disease Article Genetic Overlap & Susceptibility of Depression & Alzheimer’s Disease Depression Article The Impact of Pandemic Trauma: A Historical Perspective Schizophrenia Article Positive steps to address negative symptoms in schizophrenia Schizophrenia Congress highlights Article What should psychiatrists do to improve the physical health of patients with schizophrenia?